Fundraising FoxKalexobio
1 known investors
Find your way into Kalexobio
Sign up to find every way you can get introduced to Kalexobio
- Your email: who you already know at Kalexobio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Kalexobio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Kalexo Bio develops dual-targeting siRNA therapeutics for cardiovascular disease, with a focus on lipid management and atherosclerotic disease prevention. The company's lead program targets genetic drivers of cardiovascular risk to deliver durable risk reduction in patients.
Investors · 1
Frequently asked questions
- What does Kalexobio do?
- Kalexo Bio develops dual-targeting siRNA therapeutics for cardiovascular disease, with a focus on lipid management and atherosclerotic disease prevention. The company's lead program targets genetic drivers of cardiovascular risk to deliver durable risk reduction in patients.
- Who are Kalexobio's investors?
- Kalexobio's investors include Aditum Bio.